The Society for Cardiovascular Angiography & Interventions (SCAI) announced the publication of new, evidence-based clinical ...

Britain today live with rheumatoid arthritis (RA). Unlike osteoarthritis (OA), RA is caused not by wear and tear but by the ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published new, evidence-based clinical practice guidelines to support the treatment of chronic venous disease (CVD), a common and ...

Both regulatory-approved and pipeline treatments for moderate to severe hidradenitis suppurativa demonstrate comparable ...

A panelist discusses the evolving role of luspatercept in low-risk myelodysplastic syndrome, highlighting its broad efficacy ...

A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the ...

D. Wayne Lukas set the standard in horse racing. And the sport followed suit. Trainers wanted to be like Wayne. Owners wanted ...

The ACG has published new health maintenance recommendations for patients with IBD, which include appropriate vaccinations, ...

The US accounts for 80% to 90% of the total market for anti-MRSA antibiotics, so FDA approval is key to growing ceftobiprole's revenues, currently a minor part of its CHF 131 million ($137 million ...

Rheumatoid arthritis (RA) is an autoimmune disease that causes joint pain and inflammation. The condition is chronic, and there’s no cure. However, in recent years, new treatment options have ...

The US accounts for 80% to 90% of the total market for anti-MRSA antibiotics, so FDA approval is key to growing ceftobiprole’s revenues, according to analysts.

Medicines that fight bacteria, called antibiotics, are the main treatment for Lyme disease. It’s important to get treatment as early as possible to make a full recovery and avoid complications.